Gray Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.31M Sell
1,695
-42
-2% -$34.8K 0.5% 43
2024
Q3
$1.54M Buy
1,737
+9
+0.5% +$8.09K 0.61% 38
2024
Q2
$1.56M Sell
1,728
-16
-0.9% -$12.8K 0.68% 35
2024
Q1
$1.36M Buy
1,744
+40
+2% +$28.5K 0.61% 38
2023
Q4
$993K Buy
1,704
+12
+0.7% +$7K 0.48% 40
2023
Q3
$909K Buy
1,692
+20
+1% +$10.3K 0.47% 46
2023
Q2
$784K Buy
1,672
+295
+21% +$124K 0.39% 50
2023
Q1
$473K Buy
1,377
+354
+35% +$119K 0.26% 66
2022
Q4
$374K Buy
1,023
+360
+54% +$128K 0.22% 71
2022
Q3
$214K Buy
+663
New +$210K 0.14% 105

Other funds holding LLY

Gray Wealth Management's LLY Position: Q4 2024 in Review

Gray Wealth Management reduced its Eli Lilly (LLY) stake by 2.4% in Q4 2024, selling an estimated $34.8K and leaving 1,695 shares worth $1.31M. The position accounts for 0.5% of the portfolio, ranked #43.

Gray Wealth Management first reported a position in LLY in Q3 2022 and has held it in 10 quarters since. The position peaked at $1.56M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Gray Wealth Management held 1,695 shares of Eli Lilly worth $1.31M as of Q4 2024.
  • Gray Wealth Management sold 42 Eli Lilly shares in Q4 2024, an estimated $34.8K.
  • Eli Lilly made up 0.5% of Gray Wealth Management's portfolio in Q4 2024, its #43 holding.
  • Gray Wealth Management first reported a position in Eli Lilly in Q3 2022 and has held it in 10 quarters since.
  • Gray Wealth Management's Eli Lilly position peaked at $1.56M in Q2 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Gray Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.